The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 03, 2018

Filed:

Aug. 12, 2016
Applicant:

New Jersey Institute of Technology, Newark, NJ (US);

Inventors:

Ecevit Bilgili, Woodbridge, NJ (US);

Rajesh Dave, Princeton, NJ (US);

Anagha Bhakay, Harrison, NJ (US);

Mohammad Azad, Newark, NJ (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 9/14 (2006.01); A61J 3/00 (2006.01); A61J 3/02 (2006.01); A61K 9/51 (2006.01); B82Y 40/00 (2011.01); A61K 31/216 (2006.01); A61K 31/343 (2006.01); B05D 7/24 (2006.01);
U.S. Cl.
CPC ...
A61K 9/146 (2013.01); A61J 3/00 (2013.01); A61J 3/02 (2013.01); A61K 9/5138 (2013.01); A61K 9/5161 (2013.01); A61K 31/216 (2013.01); A61K 31/343 (2013.01); B05D 7/24 (2013.01); B82Y 40/00 (2013.01);
Abstract

The present disclosure provides improved systems and methods utilizing colloidal/ultrafine superdisintegrant-based composite particles for dispersion and/or dissolution of active pharmaceutical agents. In general, the present disclosure utilizes a surfactant-free or near surfactant-free formulation by incorporating a wet milled SDI as a dispersant in the formulation. As such, the present disclosure provides for the preparation of surfactant-free or substantially surfactant-free formulations (e.g., nano-composite micro-particle formulations) by incorporating a wet-milled superdisintegrant (SDI) as the dispersant in the formulations. The advantageous SDI particles (e.g., colloidal/ultrafine SDI particles) of the present disclosure can be used to break-up the aggregates (e.g., nanoparticle aggregates) of the active agents (e.g. poorly water-soluble drugs) in the formulations (e.g., micro-particle formulations) and enhance the recovery of the nanoparticles of active agents during aqueous re-dispersion and their dissolution rate in vitro and in vivo.


Find Patent Forward Citations

Loading…